These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
860 related articles for article (PubMed ID: 28011498)
1. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor. Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498 [TBL] [Abstract][Full Text] [Related]
2. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases. Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Bourhis A; De Luca C; Cariou M; Vigliar E; Barel F; Conticelli F; Marcorelles P; Nousbaum JB; Robaszkiewicz M; Samaison L; Badic B; Doucet L; Troncone G; Uguen A J Clin Pathol; 2020 Nov; 73(11):741-747. PubMed ID: 32273401 [TBL] [Abstract][Full Text] [Related]
4. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability. Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994 [TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B. Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861 [TBL] [Abstract][Full Text] [Related]
6. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer. Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers. de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292 [TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients. Won DD; Lee JI; Lee IK; Oh ST; Jung ES; Lee SH BMC Cancer; 2017 Jun; 17(1):403. PubMed ID: 28583095 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and prognostic impact of colorectal cancers with NRAS mutations. Ogura T; Kakuta M; Yatsuoka T; Nishimura Y; Sakamoto H; Yamaguchi K; Tanabe M; Tanaka Y; Akagi K Oncol Rep; 2014 Jul; 32(1):50-6. PubMed ID: 24806883 [TBL] [Abstract][Full Text] [Related]
10. Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations. Mouradov D; Domingo E; Gibbs P; Jorissen RN; Li S; Soo PY; Lipton L; Desai J; Danielsen HE; Oukrif D; Novelli M; Yau C; Holmes CC; Jones IT; McLaughlin S; Molloy P; Hawkins NJ; Ward R; Midgely R; Kerr D; Tomlinson IP; Sieber OM Am J Gastroenterol; 2013 Nov; 108(11):1785-93. PubMed ID: 24042191 [TBL] [Abstract][Full Text] [Related]
12. Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions. Cocco E; Benhamida J; Middha S; Zehir A; Mullaney K; Shia J; Yaeger R; Zhang L; Wong D; Villafania L; Nafa K; Scaltriti M; Drilon A; Saltz L; Schram AM; Stadler ZK; Hyman DM; Benayed R; Ladanyi M; Hechtman JF Cancer Res; 2019 Mar; 79(6):1047-1053. PubMed ID: 30643016 [TBL] [Abstract][Full Text] [Related]
13. Clinical meaning of BRAF mutation in Korean patients with advanced colorectal cancer. Kim B; Park SJ; Cheon JH; Kim TI; Kim WH; Hong SP World J Gastroenterol; 2014 Apr; 20(15):4370-6. PubMed ID: 24764675 [TBL] [Abstract][Full Text] [Related]
14. Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer. Ghanipour L; Jirström K; Sundström M; Glimelius B; Birgisson H Eur J Surg Oncol; 2017 Feb; 43(2):311-321. PubMed ID: 27836416 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160 [TBL] [Abstract][Full Text] [Related]
16. Predictive model for high-frequency microsatellite instability in colorectal cancer patients over 50 years of age. Fujiyoshi K; Yamaguchi T; Kakuta M; Takahashi A; Arai Y; Yamada M; Yamamoto G; Ohde S; Takao M; Horiguchi SI; Natsume S; Kazama S; Nishizawa Y; Nishimura Y; Akagi Y; Sakamoto H; Akagi K Cancer Med; 2017 Jun; 6(6):1255-1263. PubMed ID: 28544821 [TBL] [Abstract][Full Text] [Related]
17. Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients. Arakawa K; Hata K; Nozawa H; Kawai K; Tanaka T; Nishikawa T; Sasaki K; Shuno Y; Kaneko M; Hiyoshi M; Emoto S; Murono K; Sonoda H; Okada S; Ishihara S Anticancer Res; 2019 Mar; 39(3):1425-1432. PubMed ID: 30842178 [TBL] [Abstract][Full Text] [Related]
18. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer. Zlobec I; Kovac M; Erzberger P; Molinari F; Bihl MP; Rufle A; Foerster A; Frattini M; Terracciano L; Heinimann K; Lugli A Int J Cancer; 2010 Dec; 127(11):2569-75. PubMed ID: 20162668 [TBL] [Abstract][Full Text] [Related]
19. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer. Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534 [TBL] [Abstract][Full Text] [Related]
20. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Goldstein J; Tran B; Ensor J; Gibbs P; Wong HL; Wong SF; Vilar E; Tie J; Broaddus R; Kopetz S; Desai J; Overman MJ Ann Oncol; 2014 May; 25(5):1032-8. PubMed ID: 24585723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]